Study S001620

Pilot Weight Loss Intervention With Dual GIP/GLP-1 Receptor Agonist Therapy in Patients With Endometrial Cancer and Obesity, Overweight, With or Without Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06751589
Study type: INTERVENTIONAL
Phase: EARLY_PHASE1
Masking: NONE
Status: RECRUITING
Enrollment: 36
Start: 2024-12-19
Primary completion: 2027-12
Lead sponsor: Memorial Sloan Kettering Cancer Center
Conditions: Endometrial Cancer
Interventions: DRUG:Tirzepatide
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

percentage of patients that complete treatment [1 year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.